SAN DIEGO — At the American Society of Cataract and Refractive Surgery, Uday Devgan, MD, discusses the Juvene IOL from LensGen, which has been implanted in 95 eyes in the clinical trial to date. The unique design of the IOL aims to provide 3 D to 4 D of visual range without visual disturbances.
Uncategorized